In conclusion, this randomized, controlled trial demonstrates that IL-17A and TNF-α play an inflammatory role in the acute and subacute stages of stroke and aggravate brain injury, while VEGF-A exerts a neuroprotective effect. Here, VEGFA is linked to stroke disorder.